Biological markers of non-cancerogenic negative impacts on the central nervous system of children in the area of exposure to aluminum production emissions
- 作者: Zhdanova-Zaplesvichko I.G.1, Zemlyanova M.A.2, Koldibekova Y.V.2
-
隶属关系:
- Administration of the Federal Supervision Service for Consumer’s Rights Protection and Human Welfare in the Irkutsk Region
- Federal Scientific Center for Medical and Preventive Health Risk Management Technologies
- 期: 卷 97, 编号 5 (2018)
- 页面: 461-469
- 栏目: HYGIENE OF CHILDREN AND ADOLESCENTS
- ##submission.datePublished##: 20.10.2020
- URL: https://rjsocmed.com/0016-9900/article/view/640377
- DOI: https://doi.org/10.47470/0016-9900-2018-97-5-461-469
- ID: 640377
如何引用文章
全文:
详细
Introduction. The priority indicator of the influence of chemical factors of the environment on the health of the population of Russia is the pollution of atmospheric air, the composition of which is largely determined by regional features of production.
Material and methods. A comparative hygienic assessment of the quality of the atmospheric air of the territory with the placement of aluminum production and the territory without similar sources of emissions was conducted; a chemical-analytical and clinical laboratory examination of 135 children was carried out, with an assessment of the negative effects from the nervous system in the case of aerogenic exposure to aluminum and manganese.
Results. In the conditions of the existing quality of atmospheric air in the residential area in the zone of influence of aluminum production which forms an aerogenic exposure of substances (aluminum and manganese), possessing of the unidirectional negative impact on the central nervous system, at the level of 0.0015g/(kg∙day) the share of aluminum is 93.3%, which indicates its primary impact on the population. Children of the observation group 1 showed urine aluminum content by 3.1 times more than in comparison to observation subgroup 2 and 6.9 times in relation to the comparison group (p = 0.0001). The concentration of aluminum as a marker of inhalation exposure is substantiated, and its value more than 0.053 mg/dm3 in urine may indicate an increased risk of neurotoxic exposure. An increased prevalence (1.6-5.5 times) of the negative impact on the CNS in the form of the asthenic autonomous syndrome, as a predictor of attention deficit and hyperactivity disorder, has been shown to be associated with the aerogenic exposure to aluminum. In children with an elevated aluminum content in urine comparing to the reference level, revealed laboratory abnormalities and indices were proved to be associated with an elevated concentration of aluminum in the urine relative to the children of the comparison group: an increase in the level of neuron-specific enolase in the serum indicating an increase in the activity of damage to the blood-brain barrier; an increase in the glutamic acid content by 1.3 times, characterizing the imbalance of the neurotransmitters of the central nervous system; reduction in serum phosphorus, reflecting the antagonistic effect of aluminum, followed by an increase in the level of ionized calcium in the blood. The contribution of aluminum to the biochemical and functional indices deviation from the physiological norm accounted for from 10% to 58%. On the basis of a consistent chain of reliable dependencies, a complex of biomarkers of the asthenic autonomous syndrome and attention deficit and hyperactivity disorder associated with an elevated aluminum content in urine, including glutamic acid, neuron-specific enolase, and phosphorus is substantiated.
作者简介
I. Zhdanova-Zaplesvichko
Administration of the Federal Supervision Service for Consumer’s Rights Protection and Human Welfare in the Irkutsk Region
编辑信件的主要联系方式.
Email: noemail@neicon.ru
ORCID iD: 0000-0003-0916-0302
俄罗斯联邦
Marina Zemlyanova
Federal Scientific Center for Medical and Preventive Health Risk Management Technologies
Email: zem@fcrisk.ru
ORCID iD: 0000-0002-8013-9613
MD, Ph.D., DSci., Professor, Head of Biochemical and Cytogenetic Diagnostic Techniques Department of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation.
e-mail: zem@fcrisk.ru
俄罗斯联邦Yu. Koldibekova
Federal Scientific Center for Medical and Preventive Health Risk Management Technologies
Email: noemail@neicon.ru
ORCID iD: 0000-0002-3924-4526
俄罗斯联邦
参考
- Assessing the impact of environmental factors on the health of the population of the Irkutsk region [Otsenka vliyaniya faktorov sredy obitaniya na zdorov’e naseleniya Irkutskoy oblasti. Informatsionno–analiticheskiy byulleten’]. Irkutsk; 2015. (in Russian).
- Bagryantseva О.V., Shatrov G.N., Khotimchenko S.А., Bessonov V.V., Arnautov О.V. Aluminium: food-related health risk assessment of the consumers. Analiz riska zdorov’yu. 2016; 1 (13): 59–68. (in Russian).
- Roßbach B., Buchta M., Csanády G.A., Filser J.G., Hilla W., Windorfer K., Stork J, Zschiesche W., Gefeller O., Pfahlberg A., Schaller K.H., Egerer E., Pinzón L.C., Letzel S. Biological monitoring of welders exposed to aluminium. Toxicology Letters. 2006; 162: 239–45.
- Shugaley I.V., Garabadzhiu A.V., Ilyushin M.A., Sudarikov A.M. Some Aspects of Effect of aluminium and its compounds on living organisms [Nekotorye aspekty vliyaniya alyuminiya i ego soedinenii na zhivye organizmy]. Ekologicheskaya khimiya. 2012; 21(3): 172-86. (in Russian).
- Deloncle R., Guillard О, Clanet F., Courtois P., Piriou A. Aluminum transfer as glutamate complex through blood-brain barrier. Possible implication in dialysis encephalopathy. Biological Trace Element Research. 1990; 25: 39–45.
- Levesque L, Mizzen CA, McLachlan DR, Fraser PE. Ligand specific effects on aluminum incorporation and toxicity in neurons and astrocytes. Brain Research. 2000; 877: 191–202.
- Yokel R., The toxicology of aluminum in the brain. Neurotoxicology. 2000; 21(5): 813–829.
- Dubinina E.E., Shchedrina L.V., Neznanov N.G., Zalutskaya N.M. et al. Oxidative stress and its effect on cells functional activity of alzheimer’s disease. Biomeditsinskaya khimiya. 2015; 61(1): 57–69. (in Russian)
- Halliwell B., Packer L., Prilipco L., Christen Y. eds Reactive Oxygen Species and the Central Nervous System. In: Free Radical in the Brain. Aging, Neurological and Mental Disorders. Berlin., N. Y., London.; Springer-Verlag; 1992.
- Gres’ N.A. Slobozhanina E.I., Guzik E. eds. Elementosis of excess aluminum [Elementoz izbytka alyuminiya]. Germany: Lambert Academic Publishing; 2014 (in Russian)
- Hynd M., Scott H.L., Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer’s disease. Neurochemistry International. 2004; 45(5): 583-95.
- Tits N.U., ed. Clinical manual of Laboratory Tests [Klinicheskoe rukovodstvo po laboratornym testam]. Moscow: Unimed-press; 2003. (in Russian)
- Nicholas D.P., Thomas V.O. eds. Managing Health in the Aluminium Industry. Canada; 1997.
- Glants S. Medical and Biological Statistics [Mediko-biologicheskaya statistika]. Moscow: Practika, 1998. (in Russian)
- Fletcher R., Fletcher S., Vagner E. Clinical Epidemiology: The Basics of Evidence-Based Medicine [Klinicheskaya epidemiologiya: Osnovy dokazatel’noy meditsiny]. Moskow: Media Sfera; 1998. (in Russian).
- Zajceva N.V., Zemljanova M.A., Zhdanova-Zaplesvichko I.G., Klejn S.V. Estimation of the aerogenic impact of priority chemical factors on the health of children in the zone of influence of enterprises producing aluminum // Environmental problems of the present: identification and prevention of adverse effects of anthropogenically deterministic factors and climate changes on the environment and public health: Intern. Forum of the Scientific Council of the Russian Federation on Human Ecology and Environmental Hygiene 2017: 168-171.
- Astakhin A.V., Evlasheva O.O., Levitan B.N. Clinical and diagnostic value of myelin basic protein and neuron specific enolase in medical practice. Klinicheskaya meditsina. 2016; 11(4): 9–13. (in Russian).
- Flaten T. Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Research Bulletin. 2001; 55(2):187–196.
- Abdurasulova I.N., Klimenko V.M. The role of immune and glial cells in neurodegenerative processes. Academic Medicine (journal). 2011; 11(1): 12-29. (in Russian).
- Pugolovkin K.A., Dombrovskaya E.A. Serum neuron-specific enolase and S-100 protein levels in children with some forms of symptomatic epilepsy as reflection of disregulative pathology of central nervous system. Consilium Medicum. 2017; 2.3: 23-27. (in Russian).
- Roth F., Draguhn A. GABA Metabolism and Transport: Effects on Synaptic Efficacy. Neural Plasticity. 2012; Article ID 805830, 12. https://doi.org/10.1155/2012/805830
补充文件
